Sapheon
Santa Rosa
About Sapheon
Sapheon is a medical device company whose mission is to develop new approaches and disruptive technologies for the treatment of vascular disease. Sapheon Inc. is a medical device company whose mission is to develop new approaches and disruptive technologies for the treatment of vascular disease. The company’s current focus is the VenaSeal Sapheon Closure System, a novel treatment for venous reflux disease. With full EU regulatory approval already in place, this game-changing approach to treating veins is poised to disrupt a $1 billion worldwide market. The VenaSeal System uses a proprietary medical adhesive to close the saphenous vein, eliminating the need for surgery, ablation, anesthesia, or the use of harsh chemicals. Sapheon is actively preparing for U.S. clinical trials and FDA approval of the VenaSeal Sapheon Closure System.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $35.8M
- Funding stage: M&A
- Last round: Debt Financing (Nov 2013)
- Website: sapheoninc.com
- Phone: 919-948-3967
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/sapheon-3231252 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.